Auris Scores Big with $200M Raise for Robotics Platform
The robotics market is surging. Auris Health recent raise of $200 million to commercialize the Monarch Platform is a perfect example. The Redwood City, CA-based company has raised more than $700 million to develop and commercialize the Monarch platform - a robotic system that enables more-accurate diagnosis and treatment of small and hard-to-reach nodules in the periphery of the lung.
Monarch received FDA clearance for Monarch to perform diagnostic and therapeutic bronchoscopic procedures earlier this year. The platform uses a familiar controller interface to navigate a flexible robotic endoscope to the periphery of the lung.
âThe support of this group of world-class investors will be instrumental as Auris transitions into a commercial-stage company,â Frederic Moll, M.D., founder and CEO of Auris Health said in a release. âWe are pleased with our progress in launching the Monarch Platform, which was initiated earlier this year. This funding will enable us to expand our commercialization efforts for endobronchial applications, and will also support our mission to pioneer the next era of medical intervention across a broader spectrum of procedures.â
Surgical Robotics 2018 and Beyond
It probably doesnât need to be said that 2018 has been a banner year for companies with robotic solutions in healthcare. In addition to Auris Healthâs significant financing raise, Medtronic an...
Source: MDDI - Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news